50 results on '"De Cobelli, Ottavio"'
Search Results
2. MP67-17 PERIOPERATIVE AND LONG-TERM ONCOLOGICAL OUTCOMES AFTER LOCAL TUMOR ABLATION FOR COMPLEX (PADUA SCORE ≥10) RENAL TUMORS: A MULTICENTER ANALYSIS
3. PD23-06 SURVIVAL DIFFERENCES BETWEEN PHEOCHROMOCYTOMA AND PARAGANGLIOMA PATIENTS
4. MP74-12 IMPACT OF MAGNETIC RESONANCE IMAGING SCAN AND IMAGE ACQUISITION PROTOCOL IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER AT BIOPSY: RESULTS FROM THE PROMOD WORKING GROUP
5. PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS
6. PD19-08 EAU RISK STRATIFICATION FOR PROSTATE CANCER ACCORDING TO SYSTEMATIC BIOPSY, TARGET BIOPSY AND COMBINED BIOPSY RESULTS AND FINAL PATHOLOGY CONCORDANCE. RESULTS FROM THE PROMOD STUDY GROUP
7. MP49-13 INTERCENTER VARIABILITY IN THE ACCURACY OF RISK CALCULATORS BASED ON MRI PARAMETERS: EXTENSIVE EXTERNAL VALIDATION OF 7 CONTEMPORARY RISK CALCULATORS
8. MP01-01 INCREMENTAL DOSE-RESPONSE EFFECT OF AGE ON MORTALITY IN NON-SEMINOMA TESTIS CANCER PATIENTS
9. MP38-03 PREDICTORS AND OUTCOME OF LYMPH NODE INVOLVEMENT FOLLOWING NEOADJUVANT CHEMOTHERAPY AND RADICAL NEPHROURETERECTOMY FOR PRIMARY UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP)
10. PD11-10 THE IMPACT OF HISTOLOGY AND TYPE OF ENERGY USED ON ONCOLOGICAL OUTCOMES AFTER LOCAL TUMOR ABLATION OF SMALL RENAL MASSES
11. PD20-04 ROBOTIC DISTAL URETERECTOMY FOR HIGH-RISK DISTAL URETERAL UROTHELIAL CARCINOMA: A RETROSPECTIVE MULTICENTER COMPARATIVE ANALYSIS (ROBUUST COLLABORATIVE ANALYSIS)
12. MP38-16 SURVIVAL BENEFIT OF NEPHROURETERECTOMY IN SYSTEMIC THERAPY EXPOSED METASTATIC UPPER TRACT URINARY UROTHELIAL CARCINOMA PATIENTS
13. MP38-18 DECISIONAL AND PROGNOSTIC IMPACT OF DIAGNOSTIC URETEROSCOPY IN HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA: A MULTI-INSTITUTIONAL COLLABORATIVE ANALYSIS (ROBUUST COLLABORATIVE GROUP)
14. MP50-06 SURVIVAL OF TESTICULAR PURE TERATOMA VS. MIXED GERM CELL TUMOR PATIENTS ACROSS ALL STAGES
15. PD39-08 INTER-CENTER VARIABILITY IN POSITIVE PREDICTIVE VALUES OF PIRADS SCORE IN PATIENTS UNDERGOING PROSTATE BIOPSY: RESULTS FROM THE PROMOD STUDY GROUP
16. MP46-16 INGUINAL LYMPH NODE DISSECTION FOR PENILE CANCER: RESULTS OF A MINIMALLY INVASIVE APPROACH FROM A MULTICENTER DATABASE
17. MP46-19 COMBINED REPORTING OF SURGICAL QUALITY AND CANCER CONTROL AFTER SURGICAL TREATMENT FOR PENILE TUMORS: THE TETRAFECTA ACHIEVEMENT
18. MP40-11 RENAL FUNCTION VARIATION AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT CARCINOMA: EVALUATION IN A LARGE MULTICENTER COHORT (RADICAL NEPHROURETERECTOMY OUTCOMES (RANEO) RESEARCH CONSORTIUM)
19. PD41-02 DIAGNOSIS OF PROSTATE CANCER IN MEN TREATED WITH 5-ALPHA-REDUCATES INHIBITORS WITH MULTIPARAMETRIC MRI: RESULTS OF A MULTICENTER INTERNATIONAL COLLABORATION
20. Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy
21. MP59-10 COMPARISON OF RENAL FUNCTIONAL OUTCOMES AFTER RADICAL OR PARTIAL NEPHRECTOMY FOR COMPLEX RENAL MASS: ANALYSIS FROM THE ROSULA (ROBOTIC SURGERY FOR LARGE RENAL MASS) COLLABORATIVE GROUP
22. MP41-02 VARIANT HISTOLOGY AS PREDICTOR OF UPSTAGING AT RADICAL CYSTECTOMY FOR UROTHELIAL BLADDER CANCER
23. MP41-08 DIAGNOSTIC ACCURACY OF PREOPERATIVE LYMPH NODE STAGING OF BLADDER CANCER: A CONCORDANCE ANALYSIS OF A MULTICENTER COHORT
24. PD64-11 ROBOTIC PARTIAL NEPHRECTOMY VS. MINIMALLY INVASIVE RADICAL NEPHRECTOMY FOR CLINICAL T3A RENAL MASS: ANALYSIS FROM THE ROSULA (ROBOTIC SURGERY FOR LARGE RENAL MASS) COLLABORATIVE GROUP
25. MP67-08 SALVAGE ROBOT ASSISTED RADICAL PROSTATECTOMY VS SALVAGE RE-IRRADIATION FOR PATIENT WITH RADIO-RECURRENT PROSTATE CANCER AFTER PRIMARY RADIOTHERAPY: ONCOLOGICAL OUTCOMES
26. MP55-14 THE IMPACT OF TREATMENT MODALITY ON SURVIVAL IN PATIENTS WITH CLINICAL NODE POSITIVE BLADDER CANCER
27. PD38-10 ADDING SYSTEMATIC BIOPSY (SBX) TO MAGNETIC RESONANCE ULTRASOUND FUSION TARGETED BIOPSY (TBX) OF THE PROSTATE IN MEN WITH PREVIOUS NEGATIVE BIOPSY OR ENROLLED IN ACTIVE SURVEILLANCE PROGRAMS: A PROSPECTIVE SINGLE CENTER, RANDOMIZED, ANALYSIS
28. Reply by Authors
29. Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study
30. MP10-08 SARCOMATOID DEDIFFERENTIATION AS A PREDICTOR OF OVERALL MORTALITY IN SURGICALLY TREATED METASTATIC RENAL CELL CARCINOMA.
31. PD18-04 A PHASE 1 SAFETY STUDY OF ONCOFID-P-B ADMINISTERED FOR 12 CONSECUTIVE WEEKS IN BCG UNRESPONSIVE/INTOLERANT PATIENTS WITH BLADDER CARCINOMA IN SITU (CIS): PRELIMINARY RESULTS
32. MP32-16 INCIDENCE AND IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN CANDIDATES FOR RADICAL CYSTECTOMY: RESULTS FROM A MULTICENTER COLLABORATION
33. MP48-17 OUTCOMES OF PARTIAL VERSUS RADICAL NEPHRECTOMY IN OCTOGENARIAN PATIENTS: RESULTS FROM THE RESURGE PROJECT
34. MP26-12 TRIFECTA OUTCOMES OF PARTIAL NEPHRECTOMY IN PATIENTS OVER 75 YEARS OLD: A MULTI-INSTITUTIONAL STUDY: ANALYSIS OF THE RENAL SURGERY IN ELDERLY (RESURGE) GROUP
35. MP59-20 COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE RADICAL AND PARTIAL NEPHRECTOMY FOR CLINICAL T2 RENAL MASS: ANALYSIS OF THE ROBOTIC SURGERY FOR LARGE RENAL MASS (ROSULA) GROUP
36. MP36-10 CHEST FOLLOW-UP SCHEDULE OF SURGICALLY RESECTED RENAL CELL CARCINOMA SHOULD BE DIFFERENTIATED ACCORDING TO HISTOLOGICAL SUBTYPE
37. MP42-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR CT2 RENAL TUMORS: PERIOPERATIVE, FUNCTIONAL AND ONCOLOGICAL OUTCOMES FROM A MULTICENTER ANALYSIS (THE ROSULA PROJECT)
38. MP48-07 PATTERNS AND PREDICTORS OF RESECTION TECHNIQUES DURING PARTIAL NEPHRECTOMY FOR T1 RENAL MASSES: RESULTS OF A MULTICENTRE PROSPECTIVE COHORT STUDY FROM THE SURFACE-INTERMEDIATE-BASE (SIB) MARGIN SCORE INTERNATIONAL CONSORTIUM (IDEAL PHASE 2B)
39. MP58-14 LIMITS OF TRANSURETHRAL RESECTION IN DETECTING UNCOMMON HISTOLOGICAL VARIANTS WITHIN BULKY BLADDER TUMORS IN REAL-LIFE CLINICAL PRACTICE
40. PD49-08 TRENDS IN THE USE OF PARTIAL NEPHRECTOMY FOR CT1 RENAL TUMORS: ANALYSIS OF A 10-YR EUROPEAN MULTICENTER DATASET
41. Image Guided Hypofractionated Radiotherapy and Quality of Life for Localized Prostate Cancer: Prospective Longitudinal Study in 337 Patients
42. 1076 INDEPENDENT VALIDATION OF THE 2010 TNM STAGING SYSTEM FOR RENAL CELL CARCINOMA: DOES IT IMPROVES PREDICTIVE ACCURACY IN CANCER-SPECIFIC MORTALITY COMPARED TO 2002 TNM?
43. 922 LONG-TERM FOLLOW UP USING TESTICULAR SPARING SURGERY FOR LEYDIG CELL TUMOR
44. INTRAOPERATIVE RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER: THE EXPERIENCE OF THE EUROPEAN INSTITUTE OF ONCOLOGY
45. 242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder
46. 242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder
47. RE: AN EVALUATION OF THE DECREASING INCIDENCE OF POSITIVE SURGICAL MARGINS IN A LARGE RETROPUBIC PROSTATECTOMY SERIES
48. Re: Skeletal Fracture Associated With Androgen Suppression Induced Osteoporosis: The Clinical Incidence and Risk Factors for Patients With Prostate Cancer Reply by Authors.
49. Do Young Patients with Renal Cell Carcinoma Feature a Distinct Outcome after Surgery? A Comparative Analysis of Patient Age Based on the Multinational CORONA Database.
50. Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.